InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Friday, 08/29/2014 10:22:36 AM

Friday, August 29, 2014 10:22:36 AM

Post# of 80866
I guess that with current pricing anybody acquiring Musclepharm would have to pay close to $300 million, or $24 per share.

For now, we should probably look for breaking $14 and perhaps even $15 with positive news